Includes Thin Prep Pap with HPV
Preferred Specimen(s) Provide all patient information using the Cytology test requisition.
Specimen to be collected in thin prep vial using brush
Transport Container Thin Prep Vial
Transport Temperature Room temperature
Methodology Microscopy; signal amplification detection
Clinical Significance Liquid-based Pap Testing is intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as define by The Bethesda System for Reporting Results of Cervical Cytology. Pap screening is not reliable for the detection of endometrial cancer. Gynecologic cytology is a screening test which is subject to both false positive and false negative results. For that reason, the test is most reliable when a satisfactory sample is obtained on a regular repetitive basis. Hence, these results must be interpreted in the context of historic and current clinical information. HPV is the causative agent for cervical dysplasia and cervical cancer. HPV DNA testing in conjunction with a Pap test in women 30 years and older can be used adjunctively to assess the presence or absence of high-risk HPV types. This information, together with the physician’s assessment of cytology history, other risk factors, and professional guidelines, may be used to guide patient management. The use of this test has not been evaluated for the management of women with prior cytologic or histologic abnormalities, hysterectomy, who are postmenopausal, or who have other risk factors (e.g., HIV+, immune-compromised, DES exposure, history of STD).